Chugai Pharmaceutical Co.

Chugai Pharmaceutical Co., Ltd.
	Headquarters in Nihonbashi Mitsui Tower
Native name	中外製薬株式会社
Romanized name	Chūgai Seiyaku kabushiki gaisha
Company type	Public KK
Traded as	TYO: 4519; Nikkei 225 component;
Industry	Pharmaceutical Industry, Business import, production and development of drugs for medical sales
Founded	March 8, 1943
Headquarters	Nihonbashi Mitsui Tower, Nihonbashi Muromachi 2-1-1, Chūō, Tokyo; On the registration Headquarter: Tokyo Kita (Tokyo)
Key people	Osamu Nagayama - Chairman and Tatsuro Kosaka - CEO
Revenue	72.9 billion capital of 47 million yen. Standalone sales of 329.2 billion yen and 344.8 billion yen consolidated ; (December 2007)
Parent	Hoffmann-La Roche (61.62%)
Website	www.chugai-pharm.co.jp (in Japanese)

Chugai Pharmaceutical Co., Ltd. (中外製薬株式会社, Chūgai Seiyaku kabushiki gaisha) is a drug manufacturer operating in Japan. It is a subsidiary controlled by Hoffmann-La Roche, which owns 62% of the company as of 30 June 2014.^[1] The company is headquartered in Tokyo. Osamu Nagayama is the current representative director and chairman. Tatsuro Kosaka is the current representative director, president and CEO.

^ Cortez, Michelle Fay; Matsuyama, Kanoko (25 August 2014). "Roche Said to Have Decided Against Bid for Rest of Chugai". Bloomberg.

[1] Cortez, Michelle Fay; Matsuyama, Kanoko (25 August 2014). "Roche Said to Have Decided Against Bid for Rest of Chugai". Bloomberg.

[1]